Free Trial
NYSE:BLCO

Bausch + Lomb (BLCO) Stock Price, News & Analysis

Bausch + Lomb logo
$13.67 -0.13 (-0.93%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$13.66 -0.01 (-0.09%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bausch + Lomb Stock (NYSE:BLCO)

Key Stats

Today's Range
$13.60
$13.90
50-Day Range
$11.46
$14.66
52-Week Range
$10.45
$21.69
Volume
452,151 shs
Average Volume
1.02 million shs
Market Capitalization
$4.84 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.56
Consensus Rating
Hold

Company Overview

Bausch + Lomb Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

BLCO MarketRank™: 

Bausch + Lomb scored higher than 59% of companies evaluated by MarketBeat, and ranked 366th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch + Lomb has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Bausch + Lomb has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Bausch + Lomb's stock forecast and price target.
  • Earnings Growth

    Earnings for Bausch + Lomb are expected to grow by 29.73% in the coming year, from $0.74 to $0.96 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch + Lomb is -17.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch + Lomb is -17.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bausch + Lomb has a PEG Ratio of 1.41. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Bausch + Lomb has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    11.29% of the float of Bausch + Lomb has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch + Lomb has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Bausch + Lomb has recently increased by 22.62%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bausch + Lomb does not currently pay a dividend.

  • Dividend Growth

    Bausch + Lomb does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.29% of the float of Bausch + Lomb has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch + Lomb has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Bausch + Lomb has recently increased by 22.62%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Bausch + Lomb has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Bausch + Lomb this week, compared to 6 articles on an average week.
  • Search Interest

    4 people have searched for BLCO on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch + Lomb insiders have bought more of their company's stock than they have sold. Specifically, they have bought $248,160.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.76% of the stock of Bausch + Lomb is held by insiders.

  • Percentage Held by Institutions

    Only 11.07% of the stock of Bausch + Lomb is held by institutions.

  • Read more about Bausch + Lomb's insider trading history.
Receive BLCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch + Lomb and its competitors with MarketBeat's FREE daily newsletter.

BLCO Stock News Headlines

1 Stock Under $50 to Target This Week and 2 We Ignore
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Bausch Lomb (BLCO) Q2 Revenue Rises 5%
See More Headlines

BLCO Stock Analysis - Frequently Asked Questions

Bausch + Lomb's stock was trading at $18.06 at the start of the year. Since then, BLCO shares have decreased by 24.3% and is now trading at $13.6720.

Bausch + Lomb Corporation (NYSE:BLCO) released its earnings results on Wednesday, July, 30th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.01. Bausch + Lomb's revenue for the quarter was up 5.1% on a year-over-year basis.
Read the conference call transcript
.

Bausch + Lomb (BLCO) raised $788 million in an IPO on Friday, May 6th 2022. The company issued 35,000,000 shares at a price of $21.00-$24.00 per share.

Top institutional investors of Bausch + Lomb include Allianz Asset Management GmbH (0.22%), Cetera Investment Advisers, Simplex Trading LLC and Fountainhead AM LLC.
View institutional ownership trends
.

Shares of BLCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch + Lomb investors own include PayPal (PYPL), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Walt Disney (DIS), Intel (INTC) and Devon Energy (DVN).

Company Calendar

Last Earnings
7/30/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NYSE:BLCO
CIK
1860742
Fax
N/A
Employees
13,500
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$13.00
Potential Upside/Downside
+13.6%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
18.50
P/E Growth
1.44
Net Income
-$317 million
Net Margins
-5.58%
Pretax Margin
-8.08%
Return on Equity
2.33%
Return on Assets
1.12%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
1.55
Quick Ratio
0.98

Sales & Book Value

Annual Sales
$4.89 billion
Price / Sales
0.99
Cash Flow
$1.82 per share
Price / Cash Flow
7.53
Book Value
$18.39 per share
Price / Book
0.74

Miscellaneous

Outstanding Shares
353,804,000
Free Float
351,115,000
Market Cap
$4.84 billion
Optionable
Optionable
Beta
0.62

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:BLCO) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners